Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted aromatic n-heterocyclic compounds as inhibitors of mitogen-activated protein kinase interacting kinase 1 (MNK1) and 2 (MNK2)

Substituted aromatic n-heterocyclic compounds as inhibitors of mitogen-activated protein kinase interacting kinase 1 (MNK1) and 2 (MNK2)

US Patent 10851082 · Granted Dec 1, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted 3-amino-5-phenylbenzamide compounds as covalent inhibitors of enhanc2025
Substituted [1,2,4]triazolo[4,3-c]pyrimidines that induce degradation of embryon2025
Bifunctional compounds comprising Apcin-A and their use in the treatment of canc2025
Proteolysis-targeting chimeric molecules (PROTACs) that induce degradation of in2025
Substituted fused pyrrolo-diazepinones and uses thereof2025
Substituted heterocycles as c-MYC targeting agents2024
Substituted heterocycles as c-MYC targeting agents2024
Substituted heterocycles as c-MYC targeting agents2024
Substituted 3-amino-5-phenylbenzamide compounds as covalent inhibitors of enhanc2024
Substituted [1,2,4]triazolo[4,3-c]pyrimidin-5-amines and proteolysis-targeting c2024
Substituted pyrrolidones and piperidones as small molecule inhibitors of EZH2 an2024
Proteolysis-targeting chimeric molecules (PROTACs) that induce degradation of c-2024